Pharming Group NV (PHAR)

1.179
+0.018(+1.55%)
  • Volume:
    7,106,518
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    1.151 - 1.185

PHAR Overview

Prev. Close
1.161
Day's Range
1.151-1.185
Revenue
201.55M
Open
1.164
52 wk Range
0.66-1.419
EPS
-0.003
Volume
7,106,518
Market Cap
773.83M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
11,481,266
P/E Ratio
-
Beta
0.917
1-Year Change
50.77%
Shares Outstanding
656,348,225
Next Earnings Date
-
What is your sentiment on Pharming Group?
or
Market is currently closed. Voting is open during market hours.
  • Barclays CEO Resigns
    • ByTrade The News-

    Ireland Set To Sell Bills In Return For Markets Since Entering Bailout ConditionsEconomic Data(EU) ECB: €303M borrowed in overnight loan facility (lowest level since late...

Pharming Group NV Company Profile

Pharming Group NV Company Profile

Employees
277

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Read More

Analyst Price Target

Average6.968 (+491.052% Upside)
High33.201
Low1.100
Price1.179
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong SellBuyStrong BuyStrong BuyStrong Buy
SummaryNeutralBuyStrong BuyStrong BuyStrong Buy
  • Shes taking off today
    1
    • Sell
      1
      • they go quick road on leniolisib and u wanna sell? 🤣
        0
    • Consolideerd een beetje op het moment.
      0
      • 0.85
        0
        • Prepare for very good news, coming before the end off Q3.cheers to Pharming
          1
          • Oh dear....not the best Q2 results, but expected. Diluted EPS hasn't changed. Outlook is OK I think.
            1
            • financial results tomorrow 💪
              0
              • I’m sorry to say but this Dutch company is probably the worst stock in Holland, where it fell from 227 € to only twenty cents.
                3
                • America is waking up! Pharming is the best Healtcare / Biothechnology stock to buy in 2021! The future of this company is very good. It's up to you! Cheers to day!
                  3
                  • Here we go
                    1